Combining Inpatient and Outpatient Data for Diagnosis of Non-Valvular Atrial Fibrillation Using Electronic Health Records: A Validation Study

References

• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129(8):837–847. doi:10.1161/CIRCULATIONAHA.113.00511924345399
   PubMed Web of Science ®Google Scholar
• Haim M, Hoshen M, Reges O, Rabi Y, Balicer R, Leibowitz M. Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation. J Am Heart Assoc. 2015;4(1):e001486. doi:10.1161/JAHA.114.00148625609415
   PubMed Web of Science ®Google Scholar
• Tu K, Nieuwlaat R, Cheng SY, et al. Identifying patients with atrial fibrillation in administrative data. Can J Cardiol. 2016;32(12):1561–1565. doi:10.1016/j.cjca.2016.06.00627742459
   PubMed Web of Science ®Google Scholar
• Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S. Identifying atrial fibrillation from electronic medical data: a systematic review. Pharmacoepidemiol Drug Saf. 2012;21(1):141–147. doi:10.1002/pds.231722262600
   PubMed Web of Science ®Google Scholar
• Coorevits P, Sundgren M, Klein GO, et al. Electronic health records: new opportunities for clinical research. J Intern Med. 2013;274(6):547–560. doi:10.1111/joim.1211923952476
   PubMed Web of Science ®Google Scholar
• Jensen PB, Jensen LJ, Brunak S. Mining electronic health records: towards better research applications and clinical care. Nat Rev Genet. 2012;13(6):395–405. doi:10.1038/nrg320822549152
   PubMed Web of Science ®Google Scholar
• Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA. 2003;290(20):2685–2692. doi:10.1001/jama.290.20.268514645310
   PubMed Web of Science ®Google Scholar
• Dewland TA, Olgin JE, Vittinghoff E, Marcus GM. Incident atrial fibrillation among Asians, Hispanics, Blacks, and Whites. Circulation. 2013;128(23):2470–2477. doi:10.1161/CIRCULATIONAHA.113.00244924103419
   PubMed Web of Science ®Google Scholar
• Brophy MT, Snyder KE, Gaehde S, Ives C, Gagnon D, Fiore LD. Anticoagulant use for atrial fibrillation in the elderly. J Am Geriatr Soc. 2004;52(7):1151–1156. doi:10.1111/j.1532-5415.2004.52314.x15209654
   PubMed Web of Science ®Google Scholar
• Yuan Z, Bowlin S, Einstadter D, Cebul RD, Conners AR Jr, Rimm AA. Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized medicare beneficiaries. Am J Public Health. 1998;88(3):395–400. doi:10.2105/AJPH.88.3.3959518970
   PubMed Web of Science ®Google Scholar
• Hravnak M, Hoffman LA, Saul MI, et al. Atrial fibrillation: prevalence after minimally invasive direct and standard coronary artery bypass. Ann Thorac Surg. 2001;71(5):1491–1495. doi:10.1016/S0003-4975(01)02477-811383788
   PubMed Web of Science ®Google Scholar
• Shireman TI, Howard PA, Kresowik TF, Ellerbeck EF. Combined anticoagulant–antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke. 2004;35(10):2362–2367. doi:10.1161/01.STR.0000141933.75462.c215331796
   PubMed Web of Science ®Google Scholar
• Antani MR, Beyth RJ, Covinsky KE, et al. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation. J Gen Intern Med. 1996;11(12):713–720. doi:10.1007/BF025989849016417
   PubMed Web of Science ®Google Scholar
• Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Identifying hypertension-related comorbidities from administrative data: what’s the optimal approach? A J Med Qual. 2004;19(5):201–206. doi:10.1177/106286060401900504
   PubMed Web of Science ®Google Scholar
• Go AS, Hylek EM, Phillips KA, et al. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation. Circulation. 2000;102(1):11–13. doi:10.1161/01.CIR.102.1.1110880408
   PubMed Web of Science ®Google Scholar
• Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96(7):2455–2461. doi:10.1161/01.CIR.96.7.24559337224
   PubMed Web of Science ®Google Scholar
• Alonso A, Agarwal SK, Soliman EZ, et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;158(1):111–117. doi:10.1016/j.ahj.2009.05.01019540400
   PubMed Web of Science ®Google Scholar
• Whittle J, Wickenheiser L, Venditti LN. Is warfarin underused in the treatment of elderly persons with atrial fibrillation? Arch Intern Med. 1997;157(4):441–445. doi:10.1001/archinte.1997.004402500970119046896
   PubMedGoogle Scholar
• Glazer NL, Dublin S, Smith NL, et al. Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch Intern Med. 2007;167(3):246–252. doi:10.1001/archinte.167.3.24617296879
   PubMedGoogle Scholar
• Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA. 2001;285(18):2370–2375. doi:10.1001/jama.285.18.237011343485
   PubMed Web of Science ®Google Scholar
• Shen AY-J, Yao JF, Brar SS, Jorgensen MB, Wang X, Chen W. Racial/ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation. Stroke. 2008;39(10):2736–2743. doi:10.1161/STROKEAHA.107.50858018635860
   PubMed Web of Science ®Google Scholar
• Dublin S, French B, Glazer NL, et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med. 2006;166(21):2322–2328. doi:10.1001/archinte.166.21.232217130384
   PubMedGoogle Scholar
• Flaker GC, McGowan DJ, Boechler M, Fortune G, Gage B. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Am Heart J. 1999;137(2):307–312. doi:10.1053/hj.1999.v137.914039924165
   PubMed Web of Science ®Google Scholar
• Brass LM, Krumholz HM, Scinto JM, Radford M. Warfarin use among patients with atrial fibrillation. Stroke. 1997;28(12):2382–2389. doi:10.1161/01.STR.28.12.23829412618
   PubMed Web of Science ®Google Scholar
• Massicotte-Azarniouch D, Kuwornu JP, Carrero -J-J, et al. Incident atrial fibrillation and the risk of congestive heart failure, myocardial infarction, end-stage kidney disease, and mortality among patients with a decreased estimated GFR. Am J Kidney Dis. 2018;71(2):191–199. doi:10.1053/j.ajkd.2017.08.01629153994
   PubMed Web of Science ®Google Scholar
• Sundboll J, Adelborg K, Munch T, et al. Positive predictive value of cardiovascular diagnoses in the Danish national patient registry: a validation study. BMJ Open. 2016;6(11):012832. doi:10.1136/bmjopen-2016-012832
   PubMed Web of Science ®Google Scholar
• Rix TA, Riahi S, Overvad K, et al. Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry. Scand Cardiovasc J. 2012;46(3):149–153. doi:10.3109/14017431.2012.67372822397620
   PubMed Web of Science ®Google Scholar
• Pakhomov SS, Hemingway H, Weston SA, Jacobsen SJ, Rodeheffer R, Roger VL. Epidemiology of angina pectoris: role of natural language processing of the medical record. Am Heart J. 2007;153(4):666–673. doi:10.1016/j.ahj.2006.12.02217383310
   PubMed Web of Science ®Google Scholar
• Wang SV, Rogers JR, Jin Y, Bates DW, Fischer MA. Use of electronic healthcare records to identify complex patients with atrial fibrillation for targeted intervention. J Am Med Inform Assoc. 2017;24(2):339–344. doi:10.1093/jamia/ocw08227375290
   PubMed Web of Science ®Google Scholar